Back to Search Start Over

Stability of Beriplast® P fibrin sealant: Storage and reconstitution

Authors :
Eberhard, Ulrich
Broder, Martin
Witzke, Günther
Source :
International Journal of Pharmaceutics. Apr2006, Vol. 313 Issue 1/2, p1-4. 4p.
Publication Year :
2006

Abstract

Abstract: This study was performed to investigate the stability of Beriplast® P fibrin sealant (FS) across a range of storage conditions, both pre- and post-reconstitution. Storage stability of the FS was evaluated during long-term refrigeration (24 months) with or without interim storage at elevated temperatures (40°C for 1 week and 25°C for 1 and 3 months). Stability of individual FS components was assessed by measuring: fibrinogen content, Factor XIII activity (FXIII), thrombin activity and aprotinin potency. The package integrity of each component was also checked (sterility testing, moisture content and pH). Storage stability was also evaluated by testing the reconstituted product for adhesion (tearing force testing after mixing the solutions) and sterility. Reconstitution stability was evaluated following 3-months’ storage, for up to 50h post-reconstitution using the same tests as for the storage stability investigations. Pre-defined specifications were met for fibrinogen content, Factor XIII activity, and thrombin activity, demonstrating storage stability. Package integrity and the functionality and sterility of the reconstituted product were confirmed throughout. Reconstitution stability was demonstrated for up to 50h following reconstitution, in terms of both tearing force and sterility tests. In conclusion, the storage stability of Beriplast® P was demonstrated over a range of 24-month storage schedules including interim exposure to elevated temperature, and the reconstituted product was stable for up to 50h. [Copyright &y& Elsevier]

Details

Language :
English
ISSN :
03785173
Volume :
313
Issue :
1/2
Database :
Academic Search Index
Journal :
International Journal of Pharmaceutics
Publication Type :
Academic Journal
Accession number :
20525636
Full Text :
https://doi.org/10.1016/j.ijpharm.2005.12.001